People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Pharmaceuticals, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Manhattan Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $59.5M | $850.1M | 2010 |
| Journey Medical Corp | — | Healthtech | Series B | $19.0M | $369.4M | 2021 |
| Alacrity Biosciences Inc | — | Biotechnology | Pre-Seed | $250K | $13.8M | 2011 |
NEIL HERSKOWITZ at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside NEIL HERSKOWITZ on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Weiss | 1 | 8 |
| JUSTIN SMITH | 1 | 7 |
| Michael Weiser | 1 | 5 |
| Timothy McInerney | 1 | 4 |
| Miranda Toledano | 1 | 3 |
| Jeff Paley | 1 | 3 |
| SEAN POWER | 1 | 2 |
| Lindsay Rosenwald | 1 | 2 |
| Timothy Hofer | 1 | 2 |
| DAVID POWER | 1 | 1 |
| Douglas Abel | 1 | 1 |
| Michael McGuinness | 1 | 1 |
| Richard Steinhart | 1 | 1 |
| Claude Maraoui | 1 | 1 |
| Robyn Hunter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.